In addition, butyrate targets peroxisome proliferator-activated receptor gamma (PPARγ) a type II nuclear receptor that activates caspase-3, increases caspase-8 and -9 activity and reduces expression of XIAP and survivin leading to apoptosis in colorectal cancer cells (Caco-2 cells) [90]. Here, PPARG is linked to colorectal cancer.